北京望实智慧科技

Wangshi Wisdom is a Beijing-based biotechnology company specializing in AI-driven drug discovery (AIDD). The company integrates structural biology, computational chemistry, and deep learning to accelerate the development of innovative small molecule therapeutics. Its proprietary platform, W-Seed, focuses on addressing "undruggable" targets and optimizing lead compounds for high-value indications. Founded by experts from top academic institutions, the company aims to bridge the gap between computational predictions and experimental validation. Wangshi Wisdom has secured significant venture capital funding to advance its internal pipeline and platform capabilities.